David Corens

Janssen (Belgium)

Papers

1

Total Citations

6

H-Index

1

About

David Corens is a leading figure in the analytical chemistry of drug discovery, whose work has fundamentally advanced the speed and efficiency of pharmaceutical development. His primary research focuses on high-throughput purification and analysis, integrating techniques like reversed-phase HPLC-MS and supercritical fluid chromatography-MS to create automated platforms that accelerate the identification and isolation of drug candidates. Corens’s major contribution lies in bridging the gap between analytical separation and preparative purification, enabling chemists to rapidly screen and purify complex compound libraries. His most cited work, "Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery" (2024, 6 citations), exemplifies this impact, detailing a fully integrated system that reduces cycle times from days to hours. This innovation has been widely adopted in industrial settings, streamlining lead optimization and reducing bottlenecks in the drug pipeline. Corens’s achievements highlight his role as a key enabler of modern, data-driven medicinal chemistry, making him an essential resource for researchers seeking to merge automation with analytical rigor in the pursuit of new therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery
6 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Janssen (Belgium)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago